Evidence map›Paper›PMID 39472340›Full record

ArticleArchives of gynecology and obstetrics2024

Evaluation of endocervical curettage (ECC) in colposcopy for detecting cervical intraepithelial lesions.

Annika S Behrens, Anna K Dietl, Werner Adler, Carol Geppert, Arndt Hartmann, Antje Knöll, Matthias W Beckmann, Grit Mehlhorn, Martin C Koch, Carla E Schulmeyer and 3 more

Erratum issuedAbstract readEvaluation Study
In one paragraph

Article in Archives of gynecology and obstetrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Annika S BehrensDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. annika.behrens@uk-erlangen.de.ORCID 0000-0003-3408-548X
Anna K DietlDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Universitaetsstrasse 21-23, 91054, Erlangen, Germany.
Werner AdlerDepartment of Medical Informatics, Biometry and Epidemiology, Friedrich Alexander University of Erlangen-Nuremberg, Waldstrasse 6, 91054, Erlangen, Germany.
Carol GeppertInstitute for Pathology, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Krankenhausstrasse 8-10, 91054, Erlangen, Germany.
Arndt HartmannInstitute for Pathology, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Krankenhausstrasse 8-10, 91054, Erlangen, Germany.
Antje KnöllInstitute of Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Schlossgarten 4, 91054, Erlangen, Germany.
Matthias W BeckmannDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Universitaetsstrasse 21-23, 91054, Erlangen, Germany.
Grit MehlhornInstitute for Pathology, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Krankenhausstrasse 8-10, 91054, Erlangen, Germany.
Martin C KochDepartment of Gynecology and Obstetrics, ANregiomed Ansbach Hospital, Escherichstrasse 1, 91522, Ansbach, Germany.
Carla E SchulmeyerDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Universitaetsstrasse 21-23, 91054, Erlangen, Germany.
A SeiboldDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Universitaetsstrasse 21-23, 91054, Erlangen, Germany.
Paul GassDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Universitaetsstrasse 21-23, 91054, Erlangen, Germany.
Frederik A StuebsDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen University Hospital, Universitaetsstrasse 21-23, 91054, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDiagnostic challenges in colposcopy arise especially in women aged 50 or older, with postmenopausal status and transformation zone type 3 (TZ3). Endocervical curettage (ECC) is a valuable tool for diagnosing intracervical lesions. The aim of this retrospective analysis was to evaluate the use of ECC in colposcopy for detecting cervical intraepithelial lesions.

methodsA retrospective study was carried out of colposcopies performed in the certified Dysplasia Unit at Erlangen University Hospital between July 2016 and June 2023. Pap and human papillomavirus (HPV) results were correlated with the histologic findings via ECC, obtained during examinations or surgery. The primary outcome was the rate of accuracy between the colposcopic and histologic findings with regard to cytology, age of patients, and type of transformation zone (TZ).

resultsA total of 429 colposcopies in 413 women with histologic samples obtained via ECC were included in the final analysis. In all, 355 women had TZ3. Among patients with TZ3, evidence of high-grade lesions and invasive carcinoma was also found in women with normal or low-grade abnormal cytology. For patients with normal colposcopic findings, cervical intraepithelial neoplasia (CIN) 2 and CIN 3/adenocarcinoma in situ (AIS) were found in 56 patients (16%), and invasive carcinoma was found in four patients (0.1%).

conclusionThis analysis suggests that ECC is a valuable tool in the diagnosis of cervical intraepithelial neoplasia, especially for patients who present with a normal colposcopy of the cervix and vagina but have either recurrent abnormal cytologic findings or high-grade abnormal cytology indicating CIN 2 + .

Indexed as

ColposcopyCurettageUterine Cervical DysplasiaUterine Cervical NeoplasmsAdultAgedCervix UteriFemaleHumansMiddle AgedPapillomavirus InfectionsRetrospective StudiesYoung AdultCervical cancerCervical cancer screening assessmentCervical intraepithelial neoplasiaColposcopyCytologyEndocervical curettage

Identifiers

PMID39472340
PMCPMC11910394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.